Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Auditor change
Appointed COO
Appointed director
|
|
VERACYTE, INC. (VCYT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| Febbo Phillip G. (Chief Scientific & Med Officer) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Granted 53,182 shares
@ $0
Granted 85,858 options to buy
@ $21.96, valued at
$1.9M
|
|
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2023 |
4
| Wygant Jonathan (VP, Chief Accounting Officer) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Paid exercise price by delivering 260 shares
@ $26.72, valued at
$6.9k
|
|
| 06/06/2023 |
4
| Chambers Rebecca (CFO) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Paid exercise price by delivering 1,183 shares
@ $26.72, valued at
$31.6k
|
|
| 06/06/2023 |
4
| Stapley Marc (CEO) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Paid exercise price by delivering 3,203 shares
@ $26.72, valued at
$85.6k
|
|
| 06/06/2023 |
4
| Anderson Bonnie H (Director) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Paid exercise price by delivering 1,304 shares
@ $26.72, valued at
$34.8k
|
|
| 06/06/2023 |
4
| McGuire Annie (SVP, General Counsel) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Paid exercise price by delivering 494 shares
@ $26.72, valued at
$13.2k
|
|
| 06/01/2023 |
4
| Bhanji Muna (Director) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Sold 1,539 shares
@ $25.91, valued at
$39.9k
|
|
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2023 |
4
| EASTHAM KARIN (Director) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Sold 18,750 shares
@ $22.7757, valued at
$427k
Exercised 18,750 options to buy
@ $12.12, valued at
$227.3k
|
|
| 03/16/2023 |
4
| Anderson Bonnie H (Director) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Sold 34,000 shares
@ $22.7614, valued at
$773.9k
Exercised 34,000 options to buy
@ $5.61, valued at
$190.7k
|
|
| 03/09/2023 |
4
| Stapley Marc (CEO) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Granted 78,044 shares
@ $0
Granted 128,869 options to buy
@ $23.73, valued at
$3.1M
|
|
| 03/09/2023 |
4
| McGuire Annie (SVP, General Counsel) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Granted 23,413 shares
@ $0
Granted 38,660 options to buy
@ $23.73, valued at
$917.4k
|
|
| 03/09/2023 |
4
| Wygant Jonathan (VP, Chief Accounting Officer) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Granted 8,868 shares
@ $0
Granted 14,213 options to buy
@ $23.73, valued at
$337.3k
|
|
| 03/09/2023 |
4
| Chambers Rebecca (CFO) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Granted 26,014 shares
@ $0
Granted 42,956 options to buy
@ $23.73, valued at
$1M
|
|
| 03/03/2023 |
4
| Chambers Rebecca (CFO) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Paid exercise price by delivering 2,726 shares
@ $24.1, valued at
$65.7k
|
|
| 03/03/2023 |
4
| Stapley Marc (CEO) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Paid exercise price by delivering 6,029 shares
@ $24.1, valued at
$145.3k
|
|
| 03/03/2023 |
4
| Anderson Bonnie H (Director) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Paid exercise price by delivering 8,994 shares
@ $24.1, valued at
$216.8k
|
|
| 03/03/2023 |
4
| Wygant Jonathan (VP, Chief Accounting Officer) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Paid exercise price by delivering 1,224 shares
@ $24.1, valued at
$29.5k
|
|
| 03/03/2023 |
4
| McGuire Annie (SVP, General Counsel) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Paid exercise price by delivering 2,152 shares
@ $24.1, valued at
$51.9k
|
|
| 03/02/2023 |
4
| EASTHAM KARIN (Director) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Sold 10,000 shares
@ $25.0001, valued at
$250k
Exercised 10,000 options to buy
@ $12.12, valued at
$121.2k
|
|
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2023 |
4
| Anderson Bonnie H (Director) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Sold 63,247 shares
@ $25.1268, valued at
$1.6M
Exercised 63,247 options to buy
@ $14.34, valued at
$907k
|
|
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2022 |
4
| Kennedy Giulia C (Chief Scientific & Med Officer) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Sold 1,023 shares
@ $27.03, valued at
$27.7k
|
|
| 12/06/2022 |
4
| Kennedy Giulia C (Chief Scientific & Med Officer) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Paid exercise price by delivering 1,008 shares
@ $29.14, valued at
$29.4k
|
|
| 12/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2022 |
4
| Anderson Bonnie H (Executive Chairwoman) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Paid exercise price by delivering 2,042 shares
@ $29.14, valued at
$59.5k
|
|
| 12/05/2022 |
4
| Anderson Bonnie H (Executive Chairwoman) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Sold 34,540 shares
@ $27.8068, valued at
$960.4k
Sold 45,460 shares
@ $28.6032, valued at
$1.3M
Exercised 50,000 options to buy
@ $14.34, valued at
$717k
Exercised 30,000 options to buy
@ $5.61, valued at
$168.3k
|
|
| 11/15/2022 |
4
| Kennedy Giulia C (Chief Scientific & Med Officer) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Sold 2 shares
@ $29.34, valued at
$58.7
Exercised 2 options to buy
@ $14.34, valued at
$28.7 |
|
|
|
|